Age-related macular degeneration (AMD) affects more than 180 million people 1 and is the leading cause of blindness among elderly people worldwide. Geographic atrophy, an advanced form of AMD, is characterized by degeneration of the RPE, a monolayer of cells that provide trophic support to photoreceptors 2, 3 . Levels of the RNase DICER1 are lower in the RPE in human eyes with geographic atrophy than in unaffected eyes, thus leading to accumulation of toxic Alu mobile-element RNA transcripts 4 ; these Alu transcripts induce RPE cell death by activating the NLRP3 inflammasome 5 . Although NLRP3-inflammasome activation has been widely implicated in macular degeneration 6-8 , the mechanisms regulating the inflammasome in this disease remain elusive. Here we found that DICER1 deficit and Alu-RNA-driven RPE degeneration in mouse models of macular degeneration are mediated by caspase-4-and gasdermin D-dependent inflammasome activation. Geographic atrophy is a blinding form of age-related macular degeneration characterized by retinal pigmented epithelium (RPE) death; the RPE also exhibits DICER1 deficiency, resultant accumulation of endogenous Alu-retroelement RNA, and NLRP3-inflammasome activation. How the inflammasome is activated in this untreatable disease is largely unknown. Here we demonstrate that RPE degeneration in human-cell-culture and mouse models is driven by a noncanonical-inflammasome pathway that activates caspase-4 (caspase-11 in mice) and caspase-1, and requires cyclic GMP-AMP synthase (cGAS)-dependent interferon-b production and gasdermin D-dependent interleukin-18 secretion. Decreased DICER1 levels or Alu-RNA accumulation triggers cytosolic escape of mitochondrial DNA, which engages cGAS. Moreover, caspase-4, gasdermin D, interferon-b, and cGAS levels were elevated in the RPE in human eyes with geographic atrophy. Collectively, these data highlight an unexpected role of cGAS in responding to mobile-element transcripts, reveal cGAS-driven interferon signaling as a conduit for mitochondrial-damage-induced inflammasome activation, expand the immune-sensing repertoire of cGAS and caspase-4 to noninfectious human disease, and identify new potential targets for treatment of a major cause of blindness.
Unexpectedly, the activity of this noncanonical inflammasome was dependent on the activation of cGAS-driven type I interferon (IFN) signaling by cytosolic mitochondrial DNA (mtDNA).
RESULTS

Caspase-4 is activated in AMD
Caspase-4 (or caspase-11 in mice), which governs noncanonicalinflammasome activation, has recently been implicated in the immune response to exogenous pathogen-associated molecular patterns such as intracellular lipopolysaccharide (LPS) 9, 10 and endogenously produced oxidized phospholipids (oxidized 1-palmitoyl-2-arachidonylsn-glycero-3-phosphocholine (oxPAPC)) 11 . We found that caspase-4 abundance in the RPE and choroid in human eyes with geographic atrophy was significantly higher than that in normal human eyes from aged subjects, as monitored by western blotting (Fig. 1a and Supplementary Fig. 1a) . Introduction of in vitro-transcribed Alu RNA or plasmid-mediated enforced expression of Alu RNA (pAlu) induced and activated caspase-4 in primary human RPE cells, as mice expressing functional mouse caspase-11 from a bacterial artificial chromosome transgene (Casp1 −/− ; Casp11 129mt/129mt ; Casp11 Tg ) (n = 8 eyes) subretinally injected with vehicle (n = 11 eyes) or Alu RNA (n = 12 eyes). Bottom, immunostaining with antibody to ZO-1. For all immunoblots, cropped gel images of bands of interest of representative immunoblots from three independent experiments and densitometric analysis (mean (s.e.m.)) are shown. Tubulin, β-actin, or vinculin was used as a loading control, as indicated. In d, e, and i, the degenerated retinal area is outlined by blue arrowheads in the fundus images; loss of regular hexagonal cellular boundaries in ZO-1-stained flat mounts is indicative of degenerated RPE. RPE degeneration was assessed by binary quantification (healthy (%)) and morphometric quantification (PM, polymegethism (mean (s.e.m.))) (Fisher's exact test for binary; two-tailed t test for morphometry; *P < 0.05; **P < 0.01; ***P < 0.001). For all micrographs, scale bars, 20 µm.
evidenced by increased abundance of p30 cleavage fragments (Fig. 1b and Supplementary Fig. 1b,c) . Antisense-oligonucleotide-mediated knockdown of DICER1 similarly induced caspase-4 activation in human RPE cells (Fig. 1b) , and this effect was blocked by concomitant antisense-mediated inhibition of Alu RNA (Supplementary Fig. 1d ). Caspase-11 activation was induced by subretinal injection of Alu RNA in wild-type (WT) C57BL/6J mice ( Fig. 1c) and by Alu RNA transfection in primary RPE cells isolated from WT mice ( Supplementary  Fig. 1e ). Collectively, these data indicate that caspase-4 is preferentially activated in human AMD and that dysregulation of DICER1 and Alu RNA lead to caspase-4 activation in this condition.
Caspase-4 is required for Alu-RNA-induced RPE degeneration and inflammasome activation We sought to determine whether caspase-4 is required for Alu-RNAinduced RPE degeneration, which was quantified by both binary grading and semiautomated cellular morphometry (Online Methods and Supplementary Fig. 2) . Exogenous delivery or endogenous overexpression of Alu-RNA induced RPE degeneration in WT mice ( Fig. 1d and Supplementary Fig. 1f ). In contrast, neither Alu RNA nor pAlu injected subretinally induced RPE degeneration in caspase-11-knockout mice (denoted Casp11 −/− ; official gene symbol Casp4) ( Fig. 1d and Supplementary Fig. 1f ). 129S6 mice, which lack functional caspase-11 because of a passenger mutation 12 , were also resistant to RPE degeneration induced by Alu RNA or pAlu (Supplementary Fig. 1g ).
Subretinal delivery of a cell-permeable, nonimmunogenic cholesterolconjugated siRNA (17 + 2 nt in length) 13, 14 targeting Dicer1 induced RPE degeneration in WT but not 129S6 mice ( Supplementary  Fig. 1h ). Transgenic expression of human caspase-4 in caspase-11-deficient mice (Casp11 −/− mice expressing a human caspase-4 transgene (Casp11 −/− ; hCasp4 Tg )) 15 restored susceptibility to Alu-RNA-induced RPE degeneration (Fig. 1e) , demonstrating that human caspase-4 was able to compensate for mouse caspase-11 in this system.
Collectively, these data demonstrate the critical role of caspase-4 (or mouse caspase-11) in responding to pathological accumulation of endogenous Alu-mobile-element transcripts. Previously, we have reported that Alu RNA does not induce RPE degeneration in caspase-1-deficient mice 5 . However, this Casp1 −/− strain has subsequently been reported to also lack functional caspase-11 as a result of a passenger mutation in the 129S6 genetic background of this strain 12 ; thus, the genotype of these mice is properly referred to as Casp1 −/− ; Casp11 129mt/129mt . We sought to clarify the molecular hierarchy of caspase-1 and caspase-11 in response to Alu RNA. Whereas Alu RNA treatment induced caspase-1 activation in WT mice or RPE cells, Alu RNA did not stimulate caspase-1 activation in Casp11 −/− mice (Fig. 1f) or in primary RPE cells isolated from Casp11 −/− mice (Fig. 1g) . Reconstitution of caspase-11 into Casp11 −/− mouse RPE cells restored caspase-1 activation by Alu RNA (Supplementary Fig. 3a,b) . Moreover, Alu RNA did not induce interleukin-18 (IL-18) secretion in Casp11 −/− mouse RPE cells (Fig. 1h) . In contrast, caspase-11 was dispensable for IL-18 secretion induced by the canonical inflammasome agonist monosodium urate (MSU) (Supplementary Fig. 3c ). These data suggest that caspase-11 is required for caspase-1 activation and IL-18 secretion induced by Alu RNA.
Alu RNA did not induce RPE degeneration in Casp1 −/− ; Casp11 129mt/129mt ; Casp11 Tg mice 12 , in which mouse caspase-11 was functionally reconstituted by a bacterial-artificial-chromosome transgene ( Fig. 1i and Supplementary Fig. 3d ). Additionally, as previously observed 5 , Casp1 −/− ; Casp11 129mt/129mt mice were not susceptible to Alu-induced RPE degeneration (Fig. 1i and Supplementary Fig. 3d) , suggesting that both caspase-4/11 and caspase-1 are required for Alu toxicity.
Because we have previously demonstrated that PYCARD, an adaptor protein involved in inflammasome activation, and the purinoceptor P2X7 (encoded by P2rx7) are required for Alu toxicity 5, 16, 17 , we next assessed whether PYCARD and P2X7 might also be required for Alu-RNA-induced caspase-11 activation. Alu-RNA-induced activation of caspase-11 occurred at low levels in P2rx7 −/− but not Pycard −/− mouse RPE cells, suggesting that caspase-11 is mechanistically downstream of P2X7 and upstream of PYCARD ( Supplementary  Fig. 3e,f) . Collectively, these findings support a model of noncanonical-inflammasome activation by Alu RNA wherein caspase-4/11 functions upstream of caspase-1 activation.
Recent studies have implicated an endogenous lipid molecule, the oxidized phospholipid oxPAPC, in caspase-11-mediated noncanonical NLRP3-inflammasome activation 11 . To test whether Alu RNA promotes accumulation of this type of endogenous ligand, we extracted lipids from Alu-RNA-treated primary human RPE cells and used liquid chromatography-mass spectrometry to quantify the following products of 1-palmitoyl-2-arachidonoyl-3-phosphatidylcholine (PAPC): 1-palmitoyl-2-glutaryl-3-phosphatidylcholine (PGPC), 1-palmitoyl-2-(5-oxovaleryl)-3-phosphatidylcholine (POVPC), and 1-palmitoyl-2-hydroxy-3-phosphatidylcholine (lysoPC) ( Supplementary  Fig. 4a-c) . Compared with control cells, Alu-RNA-treated human RPE cells exhibited a twofold increase in oxPAPC PGPC and lysoPC levels ( Supplementary Fig. 4d ) concomitantly with a trend toward lower precursor PAPC levels (Supplementary Fig. 4d ). These results suggest an indirect mechanism of Alu-driven caspase-11 engagement, possibly via oxidized-phospholipid-derived damage-associated molecular patterns (DAMPs).
Gasdermin D is required for Alu-RNA-induced RPE degeneration and inflammasome activation Caspase-11-and caspase-1-dependent pyroptotic cell death can be executed by the pore-forming protein gasdermin D (encoded by Gsdmd) [18] [19] [20] . We found that Gsdmd −/− mice were resistant to Alu-RNA-induced RPE degeneration (Fig. 2a and Supplementary  Fig. 5a,b) . In agreement with the role of gasdermin D in noncanonicalinflammasome activation by intracellular LPS 19 , Alu-RNA-induced caspase-1 activation and IL-18 secretion were lower in Gsdmd −/− mouse RPE cells than in WT cells (Fig. 2b,c) . However, caspase-11 activation in Gsdmd −/− mice was not impaired (Fig. 2d) , suggesting that loss of caspase-1 activation in Gsdmd −/− mouse RPE cells was not due to an indirect effect of gasdermin D on caspase-11, and that, mechanistically, caspase-11 functions upstream of gasdermin D.
Gasdermin D must be cleaved into a pore-forming p30 fragment in order to execute pyroptosis 21 . Interestingly, although gasdermin D was required for Alu-RNA-induced RPE degeneration and IL-18 secretion, we did not observe its cleavage into a p30 fragment in Alu-RNA-treated RPE cells in cell culture or in RPE cells in vivo (Fig. 2e) ; however, as previously reported 19 , intracellular LPS induced p30 cleavage in mouse bone marrow-derived macrophages (BMDMs) (Fig. 2e) .
Next, we directly tested whether gasdermin D p30 cleavage was dispensable for the toxicity of Alu RNA by subjecting Gsdmd −/− mice to reconstitution with either WT gasdermin D (pGSDMD-WT) or a gasdermin D mutant (pGSDMD-D276A) unable to undergo cleavage into the pyroptotic p30 fragment 19 . Notably, expression of either WT or mutant gasdermin D in Gsdmd −/− mice restored susceptibility toAlu-RNA-induced RPE degeneration (Fig. 2f) , suggesting a nonpyroptotic function of gasdermin D in this system. Previously, we have demonstrated that Alu RNA induces activation of caspase-3 (refs. 4, 22) as well as caspase-8, Fas, and FasL 22 , and that this well-characterized pathway of apoptotic induction is critical for the RPE toxicity of Alu RNA. In addition, we and others have provided molecular evidence consistent with apoptosis in the RPE in human eyes with geographic atrophy 4, 23 . To further clarify the role of apoptosis in Alu-RNA-induced cell death, we performed live-cell imaging of annexin V and propidium iodide (PI) staining in primary human RPE cells. Cells treated with Alu RNA developed plasma membrane blebs and displayed an annexin V + PI − staining pattern consistent with early apoptosis. After exhibiting several hours of annexin V positivity, cells frequently swelled and became PI positive, characteristics consistent with late apoptosis or secondary necrosis 24 ( Supplementary  Fig. 6a,b) . In vivo studies recapitulated these cell culture findings: In a, f, and g, the degenerated retinal area is outlined by blue arrowheads in the fundus images; loss of regular hexagonal cellular boundaries in ZO-1-stained flat mounts is indicative of degenerated RPE. RPE degeneration was assessed by binary quantification (healthy (%)) and morphometric quantification (PM, polymegethism (mean (s.e.m.))) (Fisher's exact test for binary; two-tailed t test for morphometry; *P < 0.05; **P < 0.01; ***P < 0.001). For all micrographs, scale bars, 20 µm.
RPE flat mounts from Alu-RNA-exposed WT mice displayed predominantly annexin V + PI − cell death (Supplementary Fig. 7a ). Alu-RNA treatment of RPE cells induced cleavage of caspase-3 and poly (ADP-ribose) polymerase 1 (PARP-1) (Supplementary Fig. 7b ), further supporting induction of an apoptotic cell-death pathway. Along with our earlier demonstration that neither necrostatin-1, an inhibitor of primary necrosis, nor glycine, an inhibitor of pyroptosis 25 , blocks Alu-RNA-induced RPE degeneration 5, 22 , these findings suggest that Alu RNA promotes cell death primarily via apoptosis rather than pyroptosis or necrosis in RPE cells. Next, we explored the roles of IL-18 and gasdermin D in Alu-RNA-induced cell death. The resistance of Gsdmd −/− mice to Alu-RNA-induced RPE degeneration was overcome by administration of recombinant mature IL-18 or subretinal injection of an expression plasmid for mature IL-18, suggesting that this resistance was due to loss of IL-18 secretion (Fig. 2g) . In support of this concept, Alu RNA did not induce secretion of IL-18 in Gsdmd −/− mouse RPE cells, and this effect was rescued by treatment of the cells with either pGSDMD-WT or the p30-cleavage-incompetent pGSDMD-D276A ( Supplementary  Fig. 5c ). Additionally, whereas annexin V + cells were not visible in RPE flat mounts for Alu-RNA-treated Gsdmd −/− mice, administration of recombinant mature IL-18 led to the appearance of numerous annexin V + PI − cells (Supplementary Fig. 8 ). These results, together with our previous demonstration that IL-18 neutralization or IL-18-receptor deficiency in mice blocks Alu-RNA toxicity in vivo 5 , suggest that gasdermin D is required for Alu-RNA-induced inflammasome activation and for RPE toxicity driven by IL-18-dependent apoptosis.
GSDMD mRNA abundance was higher in the RPE in human eyes with geographic atrophy than in eyes from unaffected age-matched controls (Fig. 2h) . In contrast, we observed similar levels of transcripts of MIP-1α, IL-8, and IL-6 in geographic-atrophy and normal specimens ( Supplementary Fig. 5d ), suggesting that global elevation of proinflammatory cytokines does not occur in geographic atrophy; instead, a more specific increase occurs in the expression of inflammasome-pathway genes. We also observed higher gasdermin D protein expression in the RPE in human eyes with geographic atrophy than in eyes from unaffected age-matched controls (Fig. 2i) .
Alu-RNA-induced noncanonical-inflammasome activation is driven by type I IFN signaling
To interrogate the upstream regulation of caspase-4, we focused on IFN signaling, which is involved in activation of the caspase-11-driven noncanonical inflammasome 10 . Alu RNA did not induce RPE degeneration or caspase-11 activation in Ifnar1 −/− mice or Ifnar1 −/− mouse RPE cells (Fig. 3a,b) , which are deficient in the type I IFN-α/β receptor (IFNAR). Treatment with recombinant IFN-β increased caspase-4 abundance in human RPE cells (Fig. 3c) . Alu RNA induced secretion of IFN-β ( Fig. 3d) and phosphorylation of IRF3 ( Supplementary  Fig. 9a ), a transcription factor that induces production of IFN-β. Alu RNA also induced phosphorylation of STAT2 ( Fig. 3e and Supplementary Fig. 9a,b) , a signaling molecule activated by type I IFNs downstream of IFNAR. Alu-RNA-induced RPE degeneration was blocked by administration of an IFN-β-neutralizing antibody (Fig. 3f) . Moreover, Alu RNA did not induce RPE degeneration in Irf3 −/− or Stat2 −/− mice ( Fig. 3g and Supplementary Fig. 9c, d) , and induction of caspase-11 activation by Alu RNA was lower in Stat2 −/− mouse RPE cells than in WT cells (Supplementary Fig. 9e ). Human eyes with geographic atrophy, compared with eyes from unaffected age-matched controls, displayed pronounced IFN-β expression in the RPE (Fig. 3h,i) . Together, these data suggest that Alu-RNA-induced RPE degeneration is dependent on regulation of the noncanonical inflammasome by type I IFN signaling.
cGAS-driven IFN signaling licenses noncanonical NLRP3 inflammasomes
We sought to identify the upstream activator of IRF3-driven IFN signaling induced by Alu RNA. We have previously shown that Alu-RNAinduced RPE degeneration is independent of several IRF3-activating signaling molecules, including various RNA sensors: TLR3, TLR4, TLR9, RIG-I, MDA5, MAVS, and TRIF 5 . However, cGAS (encoded by Mb21d1) has emerged as an innate immune sensor that can activate type I IFN signaling 26 . Additionally, cGAS has also been reported to have a role in broadly inhibiting several RNA viruses 27 .
We found that Alu RNA upregulated cGAS at the mRNA and protein levels in human RPE cells ( Supplementary Fig. 10a,b) . In contrast to WT mouse RPE cells, Alu RNA did not induce IFN-β (Fig. 4a) , activate caspase-1 ( Fig. 4b and Supplementary  Fig. 10c ) or caspase-11 ( Fig. 4c) , or induce IL-18 secretion (Fig. 4d) in Mb21d1 −/− mouse RPE cells. In contrast, inflammasome activation by MSU crystals was unimpaired in Mb21d1 −/− mouse RPE cells ( Supplementary Fig. 3c ). In human RPE cells, DICER1-knockdownmediated IFN-β induction, STAT2 phosphorylation, and activation of caspase-4 and caspase-1 were all inhibited by knockdown of cGAS (Fig. 4e,f and Supplementary Fig. 10d ,e). Moreover, Alu RNA did not induce RPE degeneration in Mb21d1 −/− mice ( Fig. 4g and Supplementary Fig. 10f,g ). Additionally, reconstitution with mouse cGAS restored IFN-β induction in Mb21d1 −/− mouse RPE cells and RPE degeneration in Mb21d1 −/− mice ( Fig. 4h, Supplementary  Fig. 10h and Supplementary Fig. 11a ). Moreover, the resistance of Mb21d1 −/− mice to Alu-RNA-induced RPE degeneration was overcome by administration recombinant IFN-β or expression of IFN-β via subretinal plasmid transfection (Fig. 4i) , suggesting that this resistance was indeed due to a lack of IFN signaling.
cGAS protein was more abundant in the RPE in human eyes with geographic atrophy than in eyes from unaffected age-matched controls (Fig. 5a) . cGAS-driven IFN signaling can be transduced by the adaptor protein STING (encoded by Tmem173) 26 . Alu RNA did not induce IRF3 phosphorylation ( Supplementary Fig. 11b ,c) or activation of caspase-1 (Fig. 5b) or caspase-11 ( Fig. 5c ) in Tmem173 −/− mouse RPE cells, nor did it induce RPE degeneration in Tmem173 −/− mice ( Fig. 5d) , suggesting the involvement of the cGAS-STING signaling axis in this system. As in the case of Mb21d1 −/− mice, the resistance of Tmem173 −/− mice to Alu-RNA-induced RPE degeneration was overcome by administration of recombinant IFN-β or expression of IFN-β via subretinal plasmid transfection (Fig. 5e) , results again suggesting a requirement for IFN signaling in Alu-RNA-induced RPE degeneration.
Alu-driven cGAS activation is triggered by engagement with mtDNA cGAS is activated by cytosolic DNA but not by poly(I:C), a synthetic double-stranded RNA analog 26 . In agreement with the notion that cGAS does not recognize RNA directly, Alu RNA did not bind cGAS in an RNA immunoprecipitation assay (data not shown). Previous studies have implicated mitochondrial dysfunction in macular degeneration, including mtDNA damage, production of reactive oxygenspecies, and downregulation of proteins involved in mitochondrial energy production and trafficking 5, 28, 29 . Cytosolic escape of mitochondrial components, such as DNA and formyl peptides, has been shown to activate innate immune pathways, including cGAS 30 .
Both Alu RNA stimulation and DICER1 knockdown in human RPE cells increased the cytosolic abundance of mtDNA (Fig. 6a and Supplementary Fig. 12a,b) . To examine whether Alu RNA triggers engagement of mtDNA by cGAS, we performed a pulldown assay to assess DNA-protein interaction in Mb21d1 −/− immortalized mouse embryonic fibroblasts (MEFs) subjected to reconstitution with hemagglutinin (HA)-tagged cGAS 30 . Because these cells express HA-cGAS from a genomically integrated DNA sequence, they were expected to express HA-cGAS at levels similar to endogenous cGAS expression levels. We observed enrichment of mtDNA in cGAS immunoprecipitates of Alu-RNA-stimulated but not mock-or poly(I:C)-stimulated cells (Fig. 6b and Supplementary Fig. 12c ), suggesting that mtDNA in the cytosol engages cGAS. The positive-control transfected plasmid DNA was also enriched in the cGAS immunoprecipitate in this assay ( Supplementary Fig. 12d ). Additionally, subretinal delivery of mtDNA induced RPE degeneration in WT but not Mb21d1 −/− mice ( Supplementary Fig. 12e) . Similarly, in cell-culture studies, mtDNA-induced Ifnb mRNA levels were lower in Mb21d1 −/− than Mock Mock (i) Fundus photographs and immunofluorescence staining of ZO-1 on RPE flat mounts from eyes of Mb21d1 −/− mice subretinally injected with Alu RNA and with recombinant IFN-β (n = 6 eyes), vehicle control (n = 6 eyes), IFN-β expression plasmid (pIFNB; n = 5 eyes), or empty-vector control (n = 5 eyes). For all immunoblots, cropped gel images of bands of interest of representative immunoblots from three independent experiments and densitometric analysis (mean (s.e.m.)) are shown. In g, h, and i, the degenerated retinal area is outlined by blue arrowheads in the fundus images; loss of regular hexagonal cellular boundaries in ZO-1-stained flat mounts is indicative of degenerated RPE. RPE degeneration was assessed through binary quantification (healthy (%)) and morphometric quantification (PM, polymegethism (mean (s.e.m.))) (Fisher's exact test for binary; two-tailed t test for morphometry; *P < 0.05; **P < 0.01; ***P < 0.001). For all micrographs, scale bars, 20 µm.
in WT mouse RPE cells (Supplementary Fig. 12f ). These data indicate that Alu-RNA-induced RPE degeneration is mediated via release of mtDNA into the cytosol, subsequent interaction of mtDNA with cGAS, and induction of IFN-β expression.
The mitochondrial permeability transition pore is required for Alu-driven mtDNA release Under conditions of cellular stress, opening of the mitochondrial permeability transition pore (mPTP) leads to mitochondrial swelling, rupture, and release of mitochondrial contents into the cytosol 31 .
In cells lacking mitochondrial peptidyl-prolyl cis-trans isomerase F (PPIF, also known as cyclophilin D), a key enzyme involved in mPTP opening, mitochondria are resistant to swelling and the permeability transition 32 . Using JC-1 and cobalt-calcein assays, we found that Alu RNA induced a decrease in the mitochondrial-membrane potential (∆Ψm), which is indicative of mPTP opening, in WT but not Ppif −/− mouse RPE cells, as determined by using the potential-sensitive fluorochrome JC-1 and assessing quenching of the calcein signal ( Supplementary Fig. 12g,h ). In addition, cyclosporin A, which inhibits mPTP opening via binding to PPIF, blocked Alu-RNA-induced mPTP opening in WT cells but did not alter ∆Ψm or calcein signal intensity in Ppif −/− cells ( Supplementary Fig. 12g,h) . Collectively, these findings suggest that Alu RNA induces Ppif-dependent mPTP opening in RPE cells.
In agreement with an effect of Alu RNA on mPTP opening, Alu RNA triggered mtDNA release into the cytosol in WT but not Ppif −/− mouse RPE cells (Fig. 6c) . Ppif −/− mice were protected against Alu-RNA-induced RPE degeneration (Fig. 6d) , confirming the in vivo importance of mPTP in Alu toxicity; moreover, Alu-RNA-induced activation of caspase-1 and caspase-11 was lower in Ppif −/− mouse RPE cells than in WT cells (Fig. 6e,f) . In human RPE cells lacking mitochondrial DNA (Rho 0 ARPE19 cells), Alu RNA no longer activated caspase-4 (Fig. 6g) , nor did it induce secretion of IL-18 (Fig. 6h) or IFN-β (Fig. 6i) . Furthermore, the resistance of Ppif −/− mice to Alu-RNA-induced RPE degeneration was overcome by administration of recombinant IFN-β or expression of IFN-β via subretinal plasmid transfection (Fig. 6j) . Collectively, these data support a model wherein mPTP-driven mitochondrial permeability mediates cytosolic release of mtDNA, which in turn promotes noncanonical-inflammasome activation via engaging the cytosolic DNA sensor cGAS, which in turn induces IFN signaling.
Alu-driven RPE toxicity does not require macrophages or microglia We focused on the RPE as the cellular locus of inflammasome activation because we have previously demonstrated that the various molecular abnormalities associated with geographic atrophy-DICER1 deficiency, Alu-RNA accumulation, and elevated In d and e, the degenerated retinal area is outlined by blue arrowheads in the fundus images; loss of regular hexagonal cellular boundaries in ZO-1-stained flat mounts is indicative of degenerated RPE. RPE degeneration was assessed by binary quantification (healthy (%)) and morphometric quantification (PM, polymegethism (mean (s.e.m.))) (Fisher's exact test for binary; two-tailed t test for morphometry; *P < 0.05; **P < 0.01; ***P < 0.001). For all micrographs, scale bars, 20 µm.
levels of NLRP3, PYCARD, cleaved caspase-1, and phosphorylated IRAK1/4-are localized to the RPE layer of human eyes with geographic atrophy 4, 5 . Our current observations that elevated levels of cGAS, gasdermin D, cleaved caspase-4, and IFN-β are similarly localized to the RPE layer in diseased eyes supports the notion that this cell layer is the locus of molecular perturbations in the noncanonical-inflammasome pathway.
However, recently reported observations of macrophages and microglia in the vicinity of pathology in human eyes with geographic atrophy 33 call the functional involvement of these immune cells into question. Previously, we have demonstrated that RPE-cell-specific ablation of Myd88, the adaptor critical for IL-18-induced RPE cell death in this system, is sufficient to prevent Alu-RNA-induced RPE degeneration in mice 5 . Using mouse chimeras, we have also . For all immunoblots, cropped gel images of bands of interest of representative immunoblots from three independent experiments and densitometric analysis (mean (s.e.m.)) are shown. In d and j, the degenerated retinal area is outlined by blue arrowheads in the fundus images; loss of regular hexagonal cellular boundaries in ZO-1-stained flat mounts is indicative of degenerated RPE. RPE degeneration was assessed by binary quantification (healthy (%)) and morphometric quantification (PM, polymegethism (mean (s.e.m.))) (Fisher's exact test for binary; two-tailed t test for morphometry; *P < 0.05; **P < 0.01; ***P < 0.001). For all micrographs, scale bars, 20 µm.
demonstrated that ablation of Myd88 in circulating bone-marrowderived cells does not prevent Alu-RNA-induced RPE degeneration 5 . Nevertheless, given that macrophages and microglia are capable of inflammasome signaling, we studied their involvement more directly. We depleted macrophages by using clodronate liposomes 34 and depleted microglia by administering tamoxifen to Cx3cr1 CreER ROSA-DTA mice 35 . Although these manipulations successfully depleted macrophages and microglia, respectively, neither type of depletion blocked Alu-RNA-induced RPE degeneration in vivo, providing direct evidence that these two cell populations are dispensable for RPE toxicity in this system (Supplementary Fig. 13 ). Although these two cell types are apparently not required by Alu RNA to elicit RPE degeneration in mice, they might have subtle effects on disease pathology. In agreement with this possibility, we found that Alu RNA activated noncanonical inflammasomes in mouse BMDMs (Supplementary Fig. 14) . Similarly to the observed effects in RPE cells, the ability of Alu RNA to induce caspase-1 activation was impaired in Casp11 −/− , Mb21d1 −/− , and Gsdmd −/− BMDMs, as compared with WT BMDMs (Supplementary Fig. 14) . Collectively these findings suggest that cGAS-driven licensing of the noncanonical inflammasome by Alu RNA is not restricted to RPE cells.
DISCUSSION
Our data identify an unexpected role of the DNA sensor cGAS, the noncanonical caspase-4 inflammasome, and gasdermin D in mediating Alu-RNA-induced RPE cell death, both in mice in vivo and in human cell culture. Coupled with observations that cGAS, IFN-β, caspase-4, and gasdermin D are more abundant in the RPE in human eyes with geographic atrophy than in control unaffected eyes, our findings suggest the involvement of these proteins in the pathogenesis of this form of AMD.
cGAS was originally recognized as a sensor of exogenous and endogenous cytosolic DNA that mediates IRF3-driven IFN signaling, and previous studies have demonstrated that the enzymatic activity of cGAS cannot be activated by an RNA stimulus 26 . Nonetheless, cGAS has been reported to be critical for the antiviral response to multiple RNA viruses 27 , although the mechanistic underpinnings of this effect are not fully understood. In this context, our work provides a new view of how endogenous RNAs can activate cGAS and raises the possibility that cGAS-driven antiviral immunity may involve Alu RNA, whose levels can be stimulated by viral infections 36 , thereby leading to mitochondrial dysfunction.
Mitochondria have been increasingly implicated as gatekeepers of cell fate that have decisive roles in diverse cellular responses including apoptosis, autophagy, and innate immunity 37 . Mitochondria can facilitate the innate immune response to infection and injury via release of mitochondrial components that are recognized as DAMPs by the cell's innate immune components. Of note, mtDNA can activate multiple arms of innate immunity, including the NLRP3 inflammasome, TLR9, and cGAS/STING-driven IFN signaling 38, 39 . In particular, mtDNA can activate the NLRP3 inflammasome by directly interacting with NLRP3 (ref. 40) or by amplifying the response to an initial trigger, such as ATP or reactive oxygen species 41 ; moreover, mtDNA can activate TLR9 on neutrophils, thereby triggering systemic lung and liver inflammation 42 . In addition to engaging TLR9 and NLRP3 signaling, mtDNA has also recently been reported to be involved in the activation of cGAS signaling via cytosolic escape of mtDNA as a consequence of mitochondrial stress 30 . We have previously demonstrated that TLR9 signaling is dispensable for Alu-RNA-induced RPE degeneration 5 and that NLRP3-inflammasome priming is unaffected in mouse RPE cells lacking TLR9 (ref. 17) . Instead, our present findings show that Alu-RNA-driven cytosolic mtDNA release leads to activation of both inflammasome and cGAS signaling pathways, thus highlighting the role of mitochondria as a signaling platform that integrates various cellular-stress cues into an innate immune signaling response in autoimmune and chronic inflammatory diseases.
Beyond its role in responding to infections, cGAS has been implicated in mouse models of autoimmune diseases and mouse tumor models. Our findings expand the functional repertoire of this innate immune sensor to chronic degenerative diseases. Activation of the noncanonical NLRP3 inflammasome by caspase-4/11 has been implicated in Gram-negative bacterial infection, sepsis, and antimicrobial defense at the mucosal surface 10, 12 . To our knowledge, our study provides the first reported example of caspase-4-driven noncanonical-inflammasome activation in a noninfectious human disease. The involvement of caspase-4 and cGAS in other conditions such as systemic lupus erythematosus and diabetes mellitus, wherein Alu-RNA accumulation has been observed 43, 44 , bears future investigation. Activation of caspase-4 has been observed in conditions of endoplasmic reticulum stress 45 . Given that several human diseases including Alzheimer's disease and obesity-associated type 2 diabetes, both of which are driven by a hyperactive inflammasome, are associated with endoplasmic reticulum stress 46, 47 , it would also be worth exploring whether DICER1 deficiency and/or Alu-RNA-induced mitochondrial dysfunction and cGAS-and caspase-4-dependent inflammasome activation are linked to endoplasmic reticulum stress.
Gasdermin D has not, to our knowledge, previously been shown to be involved in a noninfectious human disease. Mechanistically, we found that gasdermin D functions downstream of caspase-11 activation and is required for Alu toxicity. The role of gasdermin D in this system appears not to be induction of pyroptosis, unlike its response to exogenous triggers such as intracellular LPS. Instead, gasdermin D supports Alu-RNA-induced RPE cell apoptosis by promoting IL-18 secretion; notably, we did not observe cleavage of gasdermin into its p30 fragment, a process required for its pyroptotic effect. Additional studies are required to determine the mechanisms that disengage the pore-forming function of gasdermin D from the inflammasomeactivating function, i.e., caspase-1 activation and IL-18 secretion. The effects of noncanonical-inflammasome-dependent gasdermin D activation might be dictated by the activating trigger (for example, exogenous versus host) or the cell type. For instance, the only other endogenous molecule known to activate caspase-11, oxPAPC, also does not induce pyroptosis but instead triggers IL-1β release from dendritic cells 11 .
The mechanisms underlying regulation of the NLRP3 inflammasome by caspase-11/4 have been elusive. Previously, we have demonstrated that Alu-RNA-induced RPE degeneration and NLRP3-inflammasome activation depend on NF-κB and P2X7 (refs. 16,17) . In our current work, we found that Alu-RNA-induced caspase-11 activation levels were low in P2rx7 −/− mouse RPE cells, suggesting that P2X7 is required for both caspase-1 and caspase-11 activation 48 . Together, our observations suggest that Alu RNA-driven NLRP3-inflammasome activation requires both caspase-11/4 and P2X7. We also observed that Alu RNA induces oxPAPC synthesis, thus suggesting that Alu RNA might recruit other DAMPs that activate the noncanonical inflammasome and result in RPE cell toxicity. Earlier reports have implicated oxidized phospholipids in the pathophysiology of age-related macular degeneration 49, 50 ; future studies to unravel the underlying molecular mechanisms should be performed.
Numerous groups using a variety of cell culture systems, animal models, and human-donor eyes have reported an important role of the inflammasome in AMD [5] [6] [7] [8] [51] [52] [53] [54] . Collectively, these studies suggest that the NLRP3 pathway is an important responder to a panoply of AMD-related molecular stressors and toxins in RPE cells, and inflammasome inhibition has attracted great interest as a therapeutic for AMD 16 . Our identification of cGAS, IFN-β, caspase-4, and gasdermin D as critical mediators in inflammasome-driven RPE degeneration expands the array of therapeutic targets for AMD.
Although there is consensus that NLRP3-inflammasome activation is detrimental to RPE cell health and survival [6] [7] [8] , similarly to the effects of NLRP3-inflammasome activation in other cell types 55, 56 , there is controversy about the role of this pathway in neovascular AMD. IL-18, a cytokine produced by NLRP3-inflammasome activation, has been reported to inhibit angiogenesis, and IL-18 neutralization has been found to increase angiogenesis in a laser-injury model of choroidal neovascularization 54 . However, we and others have been unable to replicate this antiangiogenic effect of IL-18, and the promotion of angiogenesis by an antibody to IL-18 has also been found to be due to an excipient in its preparation 57 . These conflicting data in neovascular AMD models do not, however, have any bearing on the conclusions from our current data and work by others indicating that inflammasome activation promotes RPE degeneration, a concept providing a mechanistic rationale for testing inflammasome inhibition in geographic atrophy 58 .
In summary, this study has uncovered a contribution of endogenous-retroelement transcripts to disease via their induction of mitochondrial dysfunction and cGAS signaling, which drives IFN signaling and gasdermin D and NLRP3-inflammasome activation (Supplementary Fig. 15 ). Targeting of this pathway provides a new potential therapeutic approach for preserving RPE health in agerelated macular degeneration and for treatment of a host of other inflammasome-driven diseases 58 .
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
Mice. All animal experiments were approved by the University of Kentucky's or the University of Virginia's institutional review committee and were performed in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Visual Research. Male and female mice between 6 and 10 weeks of age were used in the study. WT C57BL/6J, Ppif −/− , P2rx7 −/− and Stat2 −/− mice were purchased from The Jackson Laboratory. Gsdmd −/− , Pycard −/− , Casp11 −/− , Casp1 −/− ; Casp11 129mt/129mt , and Casp1 −/− ; Casp11 129mt/129mt ; Casp11 Tg mice, described elsewhere 12, 19, 59, 60 , were a generous gift from V. M. Dixit (Genentech). The caspase-11-deficient mice transgenically expressing human caspase-4 (Casp11 −/− ; hCasp4 Tg ) were as described earlier 15 . WT129S6 mice (carrying an inactivating passenger mutation in caspase-11) were purchased from Taconic Biosciences. Ifnar1 −/− mice were as described earlier 61 and were a generous gift from M. Aguet. Irf3 −/− mice were a generous gift from T. Taniguchi via M. David 62 . Mb21d1 −/− mice were generated by K. A. Fitzgerald (University of Massachusetts Medical School) on a C57BL/6 background using cryopreserved embryos obtained from the European Conditional Mouse Mutagenesis Program (EUCOMM) 63 . Tmem173 −/− mice were as previously described 64 . For all procedures, anesthesia was achieved by intraperitoneal injection of 100 mg/kg ketamine hydrochloride (Ft. Dodge Animal Health) and 10 mg/kg xylazine (Phoenix Scientific), and pupils were dilated with topical 1% tropicamide and 2.5% phenylephrine (Alcon Laboratories).
Fundus photography.
A TRC-50 IX camera (Topcon) linked to a digital imaging system (Sony) was used to obtain fundus photographs of dilated mouse eyes.
Subretinal injection. Subretinal injections (1 µl) in mice were performed with a Pico-Injector (PLI-100, Harvard Apparatus) or a 35-gauge needle (Ito Co.). In vivo transfection of plasmids expressing Alu sequences (pAlu) 65, 66 , emptycontrol vector (pNull), Flag-cGAS (pFlag-cGAS), Flag-GFP, mouse mature IL-18 (pIL-18ss) 57, 67 , WT mouse gasdermin D (pGSDMD-WT), the p30-cleavageincompetent mutant mouse gasdermin D (pGSMDD-D276A) 19 , IFN-β (Origene, MR226101), or mtDNA (10 ng) was achieved with 10% Neuroporter (Genlantis) as previously described 4, 5 . In vitro-transcribed Alu RNA (0.15-0.3 µg/µl), IFN-β-neutralizing antibody (10 ng; Abcam, ab24324), isotype-control IgG (Jackson ImmunoResearch, 012-000-003), recombinant IL-18 (100 ng/µl, MBL, B002-5), or IFN-β (500 mU/µl, PBL, 12410-1) were administered via subretinal injection 4, 5 . Similarly to the procedures for knockdown of Dicer1, 1 µl of cholesterol-conjugated siRNA (1 µg/µl) targeting mouse Dicer1 or scrambled-control siRNA was injected (Dicer1 siRNA: sense, CUCUGUGAGAGUUGUCCdTdT; control siRNA: sense, UAAGGCUAUGAAGAGAUdTdT). The eye used for active versus control injection was chosen randomly.
Assessment of RPE degeneration. Alu-mediated RPE degeneration was induced by exposing mice to Alu RNA, as previously described 4, 5, 16, 17, 22 . Seven days later, RPE health was assessed by fundus photography and immunofluorescence staining of zonula occludens-1 (ZO-1) on RPE flat mounts (whole mount of posterior eye cup containing RPE and choroid layers). Mouse RPE and choroid flat mounts were fixed with 4% paraformaldehyde or 100% methanol, stained with rabbit polyclonal antibodies against mouse ZO-1 (1:100, Invitrogen, 339194), and visualized with Alexa-594 (Invitrogen). All images were obtained by microscopy (model SP-5, Leica, or Axio Observer Z1, Zeiss). Imaging was performed by an operator blinded to the group assignments.
Quantification of RPE degeneration. Binary assignment. Healthy RPE cells form a polygonal tessellation with a principally hexagonal 'honeycomb' formation. RPE degeneration was assessed on the basis of disruption of the uniformity of this polygonal sheet. Two independent raters who were blinded to the group assignments assessed RPE health according to the presence or absence of morphological disruption in RPE flat mounts. Both raters deemed 100% of images as gradable. Inter-rater reliability was measured by agreement on assignments, Pearson coefficient of determination, and Fleiss κ. Fisher's exact test was used to determine statistical significance in the fraction of healthy RPE sheets across groups.
Cellular morphometry. Quantification of cellular morphometry for hexagonally packed cells was performed in a semiautomated fashion by three masked graders by adapting our previous analysis of corneal endothelial-cell density 68 . Because RPE cells when viewed en face typically exhibit a principally hexagonal morphology similar to that of the corneal endothelium, they readily lend themselves to a similar analysis strategy. We obtained measures of cell size, polymegethism (coefficient of variation of cell size), and cell density. For this analysis, microscopy images of the RPE were captured and transmitted in deidentified fashion to the Doheny Image Reading & Research Lab (DIRRL). Images in which no cell borders could be seen were excluded from further analysis (1.8%). All images were rescaled to 304 × 446 pixels to permit importation into the Konan CellCheck software (ver. 4.0.1), a commercial US FDA-cleared software that has been used for registration clinical trials. RPE cell metrics were generated by three certified reading-center graders in an independent, masked fashion. Intergrader agreement was assessed for all three metrics by computing the multiple adjusted coefficient of determination. The previously published center method was used, which entails the user selecting the center of each identifiable cell in the image [69] [70] [71] [72] . After the cell centers were defined, the software automatically generated the mean cell area, cell density, and polymegethism values. By default, the Konan software assumes a scaling factor of 124 pixels per 100 µm. On the basis of the dimensions of the original RPE image (1,024 × 1,024 pixels, 0.21 µm/pixel), the Konan-provided values were converted to the actual physical values in micrometers.
RPE degeneration was quantified on the basis of ZO-1-stained flat-mount images through two strategies:
1. Binary assignment (healthy versus unhealthy) 16, 17, 22 by two masked raters (inter-rater agreement = 98.6%; Pearson r 2 = 0.95, P < 0.0001; Fleiss κ = 0.97, P < 0.0001).
2. Semiautomated cellular morphometry analysis by three masked raters adapting our prior analysis of the planar architecture of the corneal endothelium 68 , which resembles the RPE in its polygonal tessellation. The inter-rater agreement was high for all three metrics (multiple adjusted r 2 = 0.99 (cell size), 0.72 (polymegethism, i.e., coefficient of variation of cell size), 0.99 (cell density)).
For eyes treated with Alu RNA, pAlu, and their respective controls, the interrater agreement on binary assignment was 100%, and the fraction of eyes classified as healthy was 100% for both control groups versus 0% for Alu RNA or pAlu treatments (P < 0.0001 for both comparisons, Fisher's exact test). All three morphometric features were significantly different between control treatments versus Alu RNA or pAlu treatments (P < 0.0001, t test; Supplementary Fig. 3 ). Given the similarity among all three features in differentiating healthy versus degenerated RPE cells, for all remaining groups, we quantified polymegethism, a prominent geometric feature of RPE cells in human geographic atrophy 4, [73] [74] [75] .
Human tissue. All studies on human tissue followed the guidelines of the Declaration of Helsinki. The study of deidentified tissue collected from deceased individuals and obtained from various eye banks in the United States was exempted from IRB review by the University of Virginia Institutional Review Board for Health Sciences Research, in accordance with US Health & Human Services human-subjects regulations. Donor eyes from patients with geographic atrophy, an advanced form of AMD, or age-matched patients without AMD were obtained from various eye banks. These diagnoses were confirmed through ophthalmic examination of dilated eyes before acquisition of the tissues or eyes or after examination of the eye globes post mortem. Enucleated donor eyes isolated within 6 h postmortem were immediately preserved in RNALater (Thermo Fisher). The neural retina was removed, and tissues comprising both macular RPE and choroidal tissue were snap frozen in liquid nitrogen. For eyes with geographic atrophy, RPE and choroidal tissue comprising both atrophic and marginal areas were collected.
Immunohistochemistry. Human eyes fixed in 2-4% paraformaldehyde were prepared for immunohistochemistry and stained as previously described 4, 5 . Briefly, immunohistochemical staining of fixed human eyes was performed with rabbit antibody against cGAS (0.1 µg/ml, Sigma-Aldrich, HPA031700) or IFN-β (0.2 µg/ml, Santa Cruz Biotechnology, sc-20107) and mouse antibody against gasdermin D (1.5 µg/ml, Abcam, ab57785). Rabbit or mouse IgG controls were used to ascertain the specificity of the staining. Biotin-conjugated secondary antibodies, incubation with VECTASTAIN ABC reagent, and development with Vector Blue (Vector Laboratories, AK-5001) were used to detect the bound primary antibody. Slides were washed in PBS, then mounted in Vectamount (Vector Laboratories). All images were obtained with a Zeiss Axio Observer Z1 microscope.
Real-time PCR. Total RNA purified from cells with TRIzol reagent (Invitrogen) according to the manufacturer's recommendations was DNase treated and reverse transcribed with a QuantiTect Reverse Transcription kit (QIAGEN). The RT products (cDNA) were amplified by real-time quantitative PCR (Applied Biosystems 7900 HT Fast Real-Time PCR system) with Power SYBR green Master Mix. Relative gene expression was determined by the 2 −∆∆Ct method, and 18S rRNA or GAPDH was used as an internal control. The following primers were used: human IFNB1 (forward, 5′-GCGACACTGTTCGTGTTGT C-3′ and reverse, 5′-GCCTCCCATTCAATTGCCAC-3′), human CASP4 (forward, 5′-TCTGAGGCTCTTTCCAACGC-3′ and reverse, 5′-TTTGCC CAGGGATTCCAACA-3′), human DICER (forward, 5′-AGAGGGAAAGA AAGACAACTGCT-3′ and reverse, 5′-CATGCTGAGGGGTTGCAAAG-3′), human cGAS (forward, 5′-ACGTGCTGTGAAAACAAAGAAG-3′ and reverse, 5′-GTCCCACTGACTGTCTTGAGG-3′), human 18s rRNA (forward, 5′-CGC AGCTAGGAATAATGGAATAGG-3′ and reverse, 5′-GCCTCAGTTCCGAA AACCAA-3′), human mitochondrial DNA (forward, 5′-AGCCCACTGT AAAGCTAA-3′ and reverse, 5′-TGGGTGATGAGGAATAGTGTA-3′), human GAPDH (forward, 5′-TGGAAATCCCATCACCATCT-3′ and reverse, 5′GTCTTCTGGGTGGCAGTGAT-3′), human GSDMD (forward, 5′-GCTCCATGAGAGGCACCTG-3′ and reverse, 5′-TTCTGTGTCTGCAGCACCTC-3′) mouse Ifnb1 (forward, 5′-CGTGGGAGATGTCCTCAACT-3′ and reverse, 5′-CCTGAAGATCTCTGCTCGGAC-3′), mouse Gapdh (forward, 5′-CGACTTCAA CAGCAACTCCCACTCTTCC-3′ and reverse, 5′-TGGGTGGTCCAGGGTTTC TTACTCCTT-3′), mouse 18s rRNA (forward, 5′-TTCGTATTGCGCCGCTAGA-3′ and reverse, 5′-CTTTCGCTCTGGTCCGTCTT-3′), mouse mitochondrial DNA (forward, 5′-TTCGGAGCCTGAGCGGGAAT-3′ and reverse, 5′-ATGCCTGCGGCTAGCACTGG-3′), human MIP1α (forward, 5′-CATCACTTGCTGCTGACACG-3′ and reverse, 5′-TGTGGAATCTGC CGGGAG-3′), human IL6 (forward, 5′-GTAGCCGCCCCACACAGA-3′ and reverse, 5′-CATGTCTCCTTTCTCAGGGCTG-3′), and human IL8 (forward, 5′-CACCGGAAGGAACCATCTCA-3′ and reverse, 5′-AGAGCCACGGCCAGCTT-3′).
Mitochondrial-DNA preparation. Total DNA extracted from ARPE19 cells was used to PCR amplify mtDNA segments, as previously described 76 . The purified mtDNA PCR products were subretinally delivered with 10% Neuroporter (Genlantis) as described above.
Western blotting. Cell and tissue lysates prepared in RIPA buffer were homogenized by sonication. Protein concentration was determined with a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). Equal quantities of protein (10-50 µg) prepared in Laemmli buffer were resolved by SDS-PAGE on Novex Tris-glycine gels (Invitrogen) and transferred onto Immobilon-FL PVDF membranes (Millipore). The transferred membranes were blocked in Odyssey Blocking Buffer (PBS) or 5% nonfat dry skim milk for 1 h at RT and then incubated with primary antibody at 4 °C overnight. The immunoreactive bands were visualized with species-specific secondary antibodies conjugated with IRDye (Licor, 925-32212; 925-32213; 925-32214; 925-32219; 925-32219; 925-68072; 925-68075) or HRP (KPL, 474-1516; 074-1806;474-1612). Blot images were captured with either an Odyssey imaging system or autoradiography film. The antibodies used were as follows; rabbit polyclonal anti-human and anti-mouse anti-caspase-1 (1:500, Biovision, 3019-100; 1:1,000, Invitrogen, AHZ0082; 1:200 Santa Cruz Biotechnology, sc-514), rabbit anti-caspase-1 mAb (1:1,000, Abcam ab108362), anti-human caspase-4 (1:200, Santa Cruz, 1229), anti-mouse caspase-11 (1:200, Novus Rat mAb, 17D9 NB120-10454, or 1:1,000 Abcam rabbit mAb, ab180673), anti-STAT2 (1:500, Cell Signaling, 72604), anti-pSTAT2 (1:250, Millipore, 07-224), anti-human cGAS (1:1,000, Cell Signaling, 15102), anti-VDAC-1 (1:1,000, Cell Signaling, 4661), anti-mouse IRF3 (1:500, Novus Biologicals, NBP1-78769), anti-phospho-IRF3 (1:500, Cell Signaling, 4947S, 29047), anti-HA tag (1:1,000; Cell Signaling 2367), anti-α-tubulin mouse mAb (1:50,000, Sigma-Aldrich), anti-β-actin mouse mAb (1:50,000, Sigma-Aldrich), anti-vinculin (1:2,000, Sigma-Aldrich), anti-cleaved caspase-3 (1:500, Cell Signaling, 9661), anti-PARP (1:1,000, Cell Signaling, 9542), anti-human gasdermin D (1:500, Abcam, ab57785) and anti-mouse gasdermin D mAb (1 µg/mL; a generous gift from V. M. Dixit (Genentech). Immunoblotting for activated caspase-1 in the supernatant was performed as previously described 19 . Briefly, supernatants were collected and spun down to remove floating cells. Proteins from the cell-free supernatant were precipitated by addition of sodium deoxycholate (0.15% final), then TCA (7.2% final), and incubation on ice for 30 min to overnight. Samples were spun down at 13,000g for 30 min, and pellets were washed twice with ice-cold acetone. Precipitated proteins solubilized in 4× LDS buffer with 2-mercaptoethanol were used for immunoblotting.
Cell culture. Primary mouse and human RPE cells were isolated as previously described 77 . All cells were maintained at 37 °C in a 5% CO 2 environment. Mouse RPE cells were cultured in DMEM supplemented with 20% FBS and penicillin/streptomycin antibiotics at standard concentrations; primary human RPE cells were maintained in DMEM supplemented with 10% FBS and antibiotics. The human RPE cell line ARPE19 and ARPE19 cells lacking mitochondrial DNA (Rho 0 ARPE19) were cultured as previously described 78 . Rho 0 ARPE19 cells were maintained at 37 °C in 24 mM Na 2 HCO 3 , 10% FBS, 50 µg/ml uridine, 1 mM sodium pyruvate in DMEM-F12 (Gibco, 11320-033) containing pen/strep, Fungizone, and gentamicin. ARPE19 cells were maintained in DMEM-F12 containing pen/strep, Fungizone, and gentamicin. BMDM cells were cultured in DMEM with 10% FBS and 20% L929 supernatants. Mb21d1 −/− and HA-cGAS-reconstituted Mb21d1 −/− MEFs were cultured in DMEM with 10% FBS and antibiotics 30 . 
Synthesis of in vitro-transcribed Alu
LPS transfection into BMDM cells.
Approximately 2 × 10 6 BMDM cells were cultured overnight at 37 °C in a 60-mm dish. After 4-6 h of priming with 1 µg/ml Pam3CSK4 (Invivogen, tlrl-pms), the cells were transfected with LPS (5 µg/ml final concentration, Invivogen, tlrl-3pelps, ultrapure) with FugeneHD (Promega, E2311) with a standard transfection protocol. At 16 h after transfection, cell lysates were collected and analyzed.
Extraction of mitochondria-free cytosolic fractions. Human and mouse RPE cells were either mock treated or stimulated with Alu RNA. At 24 h after Alu-RNA transfection or 48 h after transfection with scrambled or DICER1 AS oligonucleotides, the cells were harvested by trypsinization. Then 2 × 10 6 cells were used for collecting mitochondria-free cytosolic fractions with a Mitochondrial Isolation kit (Thermo Scientific 89874). Briefly, cells were resuspended in 800 µl of Reagent A and were placed on ice for 2 min; the suspension was then Dounce homogenized (ten strokes) to lyse the cells and to release nuclei, and then the suspension was incubated for 5 min on ice after addition of 10 µL Reagent B, with vortexing every minute. To this suspension, 800 µl Mitochondria Isolation Reagent C was added, and the resulting suspension was centrifuged at 700g for 10 min at 4 °C to pellet the nuclei. The supernatant containing the cytoplasmic fraction was centrifuged five times at 700g for 10 min at 4 °C to completely remove nuclei or any unlysed cells. The resulting nuclei-free cytoplasmic fraction was centrifuged at 13,000g for 15 min at 4 °C to pellet the mitochondria. The resulting supernatant was further centrifuged an additional six times at 13,000g for 15 min at 4 °C to remove all the mitochondria. The supernatant was then mice were administered with tamoxifen dissolved in corn oil (Sigma-Aldrich; 500 mg/kg dose of a 20 mg/ml solution) via oral gavage (on days −2, 0, 5, 10, and 15). On day 11, Alu RNA was delivered via subretinal injection. Alu-RNAinduced RPE degeneration was assessed as described above. Microglial depletion was confirmed by staining retinal flat mounts for F4/80. Briefly, retinal flat mounts were prepared and fixed in 2% paraformaldehyde for 1 h, and stained with RPE-conjugated F4/80 (Bio-Rad, MCA497PET) and fluorescein-labeled Griffonia simplicifolia lectin isolectin B4 (IB4, Vector Laboratories, FL-1201). All images were obtained with a Zeiss Axio Observer Z1 microscope.
Macrophage depletion. Depletion of macrophages was achieved via administering clodronate liposomes, which eliminates macrophages, in WT mice 34 . Briefly, animals received 200 µl clodronate liposomes (Liposoma LIP-01) through the tail vein on days −2 and day 0. Alu RNA or vehicle control were subretinally injected immediately after the day 0 tail-vein injection.
Statistical analyses. Real-time qPCR and ELISA data are expressed as means ± s.e.m. and were analyzed with Student's t test. The binary readouts of RPE degeneration (i.e., the presence or absence of RPE degeneration on fundus and ZO-1-stained flat-mount images) were analyzed with Fisher's exact test. Cell-morphometry data were assessed with Student's t test. P values <0.05 were deemed statistically significant. Sample sizes were selected on the basis of power analysis α = 5%; 1 -β = 80%, such that we were able to detect a minimum of 50% change, assuming a sample s.d. based on Bayesian inference. Outliers were assessed with Grubbs' test. On the basis of this analysis, no outliers were detected, and no data were excluded. Fewer than 5% of subretinal-injectionrecipient tissues were excluded on the basis of predetermined exclusion criteria (including hemorrhage and animal death due to anesthesia complications) relating to the technical challenges of this delicate procedure.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability. The data sets generated during and/or analyzed during the current study are not publicly available, owing to commercialization of research findings, but are available from the corresponding author on reasonable request. Uncropped images of blots can be found in Supplementary Figure 16 .
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Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes were selected based on power analysis alpha=5%; 1-β = 80%, such that we could detect a minimum of 50% change assuming a sample SD based on Bayesian inference.
Data exclusions
Describe any data exclusions. No data were excluded, however some animals (<5%) were excluded from the experiements due to technical challenges in the procedures such as hemorrhage and animal death due to anesthesia complications, etc.
Replication
Describe whether the experimental findings were reliably reproduced.
The experimental findings were reliably reproduced through repeated experiments.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For in vivo studies both male and female mice were randomly distributed into treatment groups within each genotype.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
To eliminate operator bias, the researchers performing the procedures and analyses were blinded to mouse genotype identity as well as the identity of the experimental groups.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
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